07:21 AM EDT, 10/22/2024 (MT Newswires) -- Quest Diagnostics ( DGX ) reported Q3 adjusted earnings Tuesday of $2.30 per diluted share, up from $2.22 a year earlier.

Analysts polled by Capital IQ expected $2.26.

Net revenue for the quarter ended Sept. 30 was $2.49 billion, compared with $2.30 billion a year earlier.

Analysts polled by Capital IQ expected $2.42 billion.

For fiscal 2024, the company said it now expects adjusted EPS of $8.85 to $8.95, compared with its previous guidance range of $8.80 to $9. Net revenue for the year is now expected to range between $9.80 billion and $9.85 billion, versus $9.50 billion to $9.58 billion anticipated previously, it added.

Analysts surveyed by Capital IQ are looking for normalized EPS of $8.89 on revenue of $9.66 billion.

Price: 145.99, Change: -1.38, Percent Change: -0.94